Delivery Order SPE2DR25D2211-SPE2DR26FM6B2
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,180.52 on December 10, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, with an ultimate completion date of December 11, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a ceiling value of $1,801.80 and an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,445.08 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors. This is a firm fixed price, non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of November 6, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $1,435.89. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $2,700.77. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was awarded on a non-competitive basis as part of a broader procurement relationship between DLA and the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a contract value of $1,308.24. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is due for completion by November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $2,616.66 with a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a contract ceiling value of $1,380.46 and an ultimate completion date of July 15, 2025. This is a firm fixed-price, non-set-aside delivery order reflecting a routine pharmaceutical procurement under the company's existing contract vehicle. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $4,059.96. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the major pharmaceutical distributor. The contract has an ultimate completion date of September 15, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DR25D2211Indefinite Delivery Contract
- SPE2DR25D2211-SPE2DR26FM6B2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $3,164.74. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a comprehensive global pharmaceutical support vehicle, the parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The current delivery order for Trulicity, a diabetes medication, represents routine pharmaceutical fulfillment under this expansive framework contract supporting the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 12/7/25 |